Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 10 Mar 2023 for Myovant Sciences Ltd..
Filing timeline
BuySaleDavid C. Marek
Insider track record
Disclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
David C. Marek: trading record in brief
All filings by David C. Marek on record concern Myovant Sciences Ltd., in the capacity of chief executive. In total, 10 filings cover trades dated from 15 January 2021 to 10 March 2023.
Every open-market trade on record is a sale: 5 sales worth €1.1M. The rest of the record consists of 3 share grants. In 2023 alone, the filings show no purchases and 1 sale.
The newest entry dates from 10 March 2023: a transaction, in Myovant Sciences Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David C. Marek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
95,675 sharesCommon SharesSEC:0001209191-23-017720:0
8,037 shares@ US$26.8914.5% of flowCommon SharesSEC:0001209191-23-004282:0
11,156 shares@ US$25.2020.7% of flowCommon SharesSEC:0001209191-22-054196:0
11,164 shares@ US$12.8710.3% of flowCommon SharesSEC:0001209191-22-042688:0
24,594 shares@ US$10.4521.2% of flowCommon SharesSEC:0001209191-22-025170:0
134,567 shares0Common SharesSEC:0001209191-22-024784:0
19,882 shares@ US$14.6822.9% of flowCommon SharesSEC:0001209191-22-004396:0
7 of 7 declarations
